Skip to main content
. 2020 May 8;254:117765. doi: 10.1016/j.lfs.2020.117765

Table 7.

Vaccines under the clinical trials.

S. no. Vaccine Clinical trials
1. LV-SMENP-DC vaccine and antigen-specific CTLs Phase 1/Phase 2 (NCT04276896)
2. Pathogen-specific artificial antigen presenting cells (aAPC) Phase 1 (NCT04299724)
3. mRNA-1273 vaccine Phase 1 (NCT04283461)
4. ChAdOx1 nCoV-19 vaccine Phase 1/Phase 2 (NCT04324606)
5. Recombinant novel CoV vaccine (adenovirus type 5 vector) Phase 1 (NCT04313127)
6. Bacillus Calmette–Guérin (BCG) vaccine Phase 1 (EudraCT: 2020-000919-69)
HHS Vulnerability Disclosure